In a 62-year-old woman with no comorbidities, hemoglobin 6 g/dL, blood‑tinged mucus, prior mildly elevated alkaline phosphatase with normal gamma‑glutamyl transferase, a history of intravenous iron sucrose without post‑infusion hemoglobin checks, and prolonged bleeding from minor wounds, what is the most likely diagnosis?

Diagnosis: Iron Deficiency Anemia with Underlying Gastrointestinal Pathology (Likely Malignancy)

This 62-year-old woman with severe anemia (Hb 6 g/dL), blood-tinged mucus, prolonged bleeding from minor wounds, and a history of inadequately treated iron deficiency requires urgent bidirectional gastrointestinal endoscopy to rule out gastrointestinal malignancy, which is the most likely diagnosis given her presentation.

Critical Clinical Context

This patient presents with multiple red flags that demand immediate investigation:

• Severe anemia (Hb 6 g/dL) in a postmenopausal woman without comorbidities
• Blood-tinged mucus suggesting active GI bleeding
• Prolonged bleeding from minor wounds indicating severe iron deficiency affecting hemostasis
• Failed iron replacement therapy (received IV iron sucrose 4-5 times without documented response or follow-up)
• Mildly elevated alkaline phosphatase (140.8 U/L) with normal GGT 5 years ago

Why Gastrointestinal Malignancy is Most Likely

Approximately one-third of postmenopausal women presenting with iron deficiency anemia have an underlying pathological abnormality, most commonly in the gastrointestinal tract 1. The British Society of Gastroenterology guidelines explicitly state that IDA can be caused by a range of GI pathologies including cancer, and GI investigation on an urgent basis should be considered in adults with new diagnosis of IDA without obvious explanation 1.

The combination of:

• Severe, refractory anemia despite IV iron
• Blood-tinged mucus (suggesting upper or lower GI source)
• Postmenopausal status (eliminating menstrual blood loss)
• No other comorbidities to explain the anemia

...makes GI malignancy the primary concern. Unexplained IDA in all at-risk individuals is an accepted indication for fast-track secondary care referral in the UK because GI malignancies can present in this way, often in the absence of specific symptoms 1.

Understanding the Alkaline Phosphatase Finding

The mildly elevated ALP (140.8 U/L) with normal GGT from 5 years ago is less concerning for current malignancy but warrants consideration. Research shows that isolated elevated ALP of unclear etiology is most commonly associated with underlying malignancy (57% of cases), with 61 patients having infiltrative intrahepatic malignancy and 52 having bony metastasis 2. However, her ALP elevation was mild and occurred 5 years ago with normal GGT, making hepatobiliary disease or metastatic disease less likely at that time.

The Bleeding Diathesis Explained

The prolonged bleeding from minor wounds is not a primary coagulation disorder but rather a consequence of severe iron deficiency. Iron deficiency affects platelet function and can impair hemostasis. This is distinct from inherited bleeding disorders like von Willebrand disease, which would have manifested earlier in life with a positive family history 3.

Immediate Diagnostic Workup Required

1. Urgent Bidirectional Endoscopy

Bidirectional GI endoscopy is the standard diagnostic approach to examination of the upper and lower GI tract 1. This patient requires:

• Upper endoscopy (EGD) to evaluate for gastric or esophageal malignancy, peptic ulcer disease, or other upper GI bleeding sources
• Colonoscopy to evaluate for colorectal malignancy, polyps, or other lower GI pathology

2. Laboratory Confirmation of Iron Deficiency

Before proceeding, confirm iron deficiency with:

• Serum ferritin (most important single test)
• Transferrin saturation
• Complete blood count with indices (MCV, MCH)

In the absence of inflammation, serum ferritin <30 mcg/L confirms iron deficiency. If there's any evidence of inflammation (elevated CRP), use ferritin <100 mcg/L as the threshold 4, 5.

3. Additional Testing

• Celiac serology (tissue transglutaminase antibodies) - celiac disease is a common cause of iron malabsorption in the UK 1
• H. pylori testing - can cause iron deficiency through chronic gastritis 5
• Stool for occult blood (though likely positive given blood-tinged mucus)
• Repeat liver function tests to assess current ALP and GGT levels

4. If Initial Endoscopy is Negative

If bidirectional endoscopy is unrevealing and anemia persists, consider:

• Video capsule endoscopy to evaluate the small bowel for occult bleeding sources, angioectasias, or small bowel tumors 6
• CT enterography as an alternative imaging modality
• Repeat endoscopy if rebleeding occurs 6

Management of Severe Anemia

Immediate Iron Replacement

This patient requires intravenous iron as first-line treatment given her severe anemia (Hb <10 g/dL) and history of inadequate response to previous IV iron 7.

Intravenous iron should be considered as first-line treatment in patients with hemoglobin below 10 g/dL 7. Use the simple dosing scheme:

• For Hb 7-10 g/dL and body weight ≥70 kg: 2000 mg total dose
• For Hb 7-10 g/dL and body weight <70 kg: 1500 mg total dose 7

Ferric carboxymaltose allows administration of 500-1000 mg per dose, which can be delivered within 15 minutes 7. Iron sucrose requires repeated dosing limited to 200-300 mg per treatment episode 7, 8.

Critical Monitoring

All patients receiving IV iron require periodic monitoring of hematologic and iron parameters (hemoglobin, hematocrit, serum ferritin, and transferrin saturation) 8. This patient's previous failure to check hemoglobin after iron infusions represents suboptimal care.

An increase in hemoglobin of at least 2 g/dL within 4 weeks of treatment is an acceptable speed of response 7. If this doesn't occur, investigate for:

• Ongoing blood loss
• Malabsorption
• Bone marrow pathology
• Concurrent B12 or folate deficiency 1

Blood Transfusion Consideration

Blood transfusion should be reserved for those with severe symptomatic and/or circulatory compromise 1. With Hb of 6 g/dL, assess for:

• Hemodynamic instability
• Cardiac symptoms (chest pain, severe dyspnea)
• Altered mental status

If transfusion is needed, target Hb of 70-90 g/L (80-100 g/L if coronary artery disease) 1. Since a unit of packed red cells contains about 200 mg of elemental iron, restrictive transfusion should be followed by adequate iron replacement 1.

Common Pitfalls to Avoid

1. Do not assume previous IV iron was adequate - This patient received iron without documented hemoglobin response, suggesting either inadequate dosing, ongoing blood loss, or malabsorption
2. Do not delay endoscopy for iron repletion - Investigation and treatment should occur simultaneously
3. Do not attribute bleeding to "old age" - This requires thorough investigation
4. Do not overlook celiac disease - Common cause of refractory iron deficiency in the UK 1
5. Do not forget to monitor iron parameters after treatment - Essential to document response and guide further therapy 8

Prognosis Considerations

Research on isolated elevated ALP shows that 47% of patients died within an average of 58 months after identification, with malignancy being the most common cause 2. While her ALP elevation was 5 years ago and mild, this underscores the importance of thorough malignancy screening in this population.

The key to improving morbidity and mortality in this patient is rapid diagnosis of the underlying cause of her iron deficiency anemia, which is most likely gastrointestinal malignancy, followed by appropriate treatment of both the underlying condition and aggressive iron repletion.